Dutch specialty ingredients maker of lactic acid, bioplastics precursors, food-preservation ingredients and biomedical polymers.
Dutch specialty ingredients maker of lactic acid, bioplastics precursors, food-preservation ingredients and biomedical polymers.
Sells ingredients that food makers add to keep bread, meat and snacks fresh, charged by volume and tailored to each recipe, with the lactic-acid chain that underpins them also feeding bioplastics. The PLA bioplastic is made in a 50-50 joint venture with TotalEnergies, so it earns a share of that venture's profit rather than direct sales.
In one line: A specialty biochemicals maker of lactic acid and food-preservative ingredients.
Moat: narrow (process know-how, IP / patents). Fermentation process know-how and a bioplastics joint venture with TotalEnergies.
Headquarters: Amsterdam, Netherlands · Founded: 1919 · Employees: 2,408
Size Corbion (CRBN.AS) is a Netherlands Consumer Staples company (Food: Specialty/Candy) with a market value of $1.64B, the 45th largest of 60 Netherlands companies the cockpit tracks. Shares closed at €25.90 on 18 Nov 2026.
Performance Over six months the shares gained 27.2%, against -2.1% for the median peer and -4.8% for the Netherlands market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue fell 3.4% over the last twelve months (peer median +3.0%); the operating margin is 7.6% (peer median 8.4%).
Valuation It trades at 18.9× forward earnings against a peer median of 19.3× (11th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 1.7 points below its cost of capital (7.4% WACC).
Next results Next results expected around 26 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €1.25B | €1.27B | €1.29B | €1.26B | €1.46B |
| Revenue growth | — | -2% | +2% | -13% | — |
| Gross profit | €310M | €330M | €312M | €305M | €324M |
| EBITDA | €181M | €203M | €170M | €168M | €176M |
| Net income | €62.2M | €74.8M | €54.4M | €72.9M | €90.0M |
| Free cash flow | €75.6M | €92.7M | €99.9M | €20.7M | -€183M |
| Capital expenditure | €68.6M | €68.2M | €84.2M | €149M | €236M |
| Total debt | n/a | €447M | €509M | €786M | €759M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Corbion CRBN.AS | $1.64B | +27% | -3% | 8% | 18.9× | 11.2% |
| DSM-Firmenich DSFIR.AS | $27.5B | +47% | -45% | 8% | 28.6× | 23.7% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CRBN.AS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +6.7% | +2.2% | 4th highest of 21 |
| 6-month return | +27.2% | -2.1% | 3rd highest of 21 |
| Distance from 52-week high | -6.7% | -20.6% | 6th highest of 21 |
| Revenue growth (TTM) | -3.4% | +3.0% | 5th lowest of 21 |
| Operating margin | 7.6% | 8.4% | 10th lowest of 21 |
| Forward P/E | 18.9× | 19.3× | 11th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | 11.2% | 2.6% | 5th most demanding of 17 |
| Growth delivered (Del g) | +5.1% | +7.7% | 5th lowest of 17 |
| Hurdle (Req g minus delivered) | +6.1 pp | -6.8 pp | 3rd most demanding of 17 |
| ROIC minus cost of capital | -1.7 pp | +3.6 pp | 3rd lowest of 21 |
| EV / EBITDA | 10.9× | 10.5× | 7th most expensive of 14 |
| Net debt / EBITDA | 2.7× | 0.4× | 3rd most indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Corbion CRBN.AS | Netherlands | $1.64B | +27% | -3% | 8% | 18.9× | 11.2% | +5.1% |
| Nomad Foods NOMD | United States | $1.61B | +10% | +3% | 13% | 7.4× | -3.6% | +3.6% |
| Three Squirrels 300783.SZ | China | $1.68B | -12% | -13% | 2% | 21.8× | 19.8% | +0.8% |
| Chacha Food 002557.SZ | China | $1.59B | -2% | +8% | 8% | 17.3× | n/a | n/a |
| Sanquan Foods 002216.SZ | China | $1.58B | -15% | +7% | 5% | 18.5× | 3.0% | -1.1% |
| Yantai North Andre Juice 2218.HK | Hong Kong | $1.72B | +4% | -14% | 18% | 16.6× | 17.2% | +14.0% |
| NIPPN 2001.T | Japan | $1.55B | +10% | +2% | 5% | 11.8× | n/a | n/a |
| Kagome 2811.T | Japan | $1.54B | +11% | +3% | 7% | 24.8× | 2.6% | +10.0% |
| Nongshim 004370.KS | South Korea | $1.52B | -10% | +6% | 6% | 11.0× | -17.9% | +5.9% |
| Cloetta CLA-B.ST | Sweden | $1.77B | +21% | +1% | 14% | 20.1× | 0.0% | +8.4% |
| Robertet RBT.PA | France | $1.78B | 0% | 0% | 15% | 17.9× | -0.4% | +9.4% |
| J & J Snack Foods JJSF | United States | $1.85B | +35% | -4% | 6% | 25.1× | 9.1% | +5.8% |
| Anhui Jinhe Industrial 002597.SZ | China | $1.87B | -10% | +22% | 4% | 24.0× | 10.9% | +6.0% |
| Qianhe Condiment & Food 603027.SS | China | $1.38B | -18% | -6% | 14% | 24.0× | 2.5% | +8.8% |
| CCL Products (India) CCL.NS | India | $1.36B | -13% | +24% | 13% | 25.4× | 17.8% | +29.1% |
| Gambol Pet 301498.SZ | China | $1.99B | -30% | +14% | 7% | 38.5× | n/a | n/a |
| Morinaga & 2201.T | Japan | $1.32B | +1% | +5% | 9% | 12.6× | -5.6% | +7.1% |
| Chongqing Fuling Zhacai 002507.SZ | China | $2.03B | -3% | +3% | 28% | 18.1× | -1.0% | +1.4% |
| UTZ Brands UTZ | United States | $2.05B | +85% | 0% | 0% | 20.7× | n/a | n/a |
| Weilong Delicious Global 9985.HK | Hong Kong | $2.08B | -20% | +13% | 25% | 9.0× | -7.4% | +11.1% |
| Bikaji Foods International BIKAJI.NS | India | $1.28B | -29% | +13% | 9% | 42.4× | 39.9% | +17.5% |